Elena Avila – Vector Bioscience

Catalyze Interviews Vector Bioscience’s CEO, Lluna Gallego, on Advancing RNA Delivery in Oncology

We are pleased to share a recent interview with our CEO and Co-Founder, Lluna Gallego, conducted by Catalyze, an innovation […]

Elena Avila / February 6, 2026

This year’s Nobel Prize in Chemistry has been awarded to the pioneers of MOFs, recognising a class of materials that

Elena Avila / November 12, 2025

Vector Bioscience Cambridge has been selected to join the Future Medicines Accelerator, a programme delivered by LYVA Labs and funded

Elena Avila / August 14, 2025

At Vector Bioscience Cambridge, we work in close collaboration with Prof. David Fairen-Jimenez’s research group at the University of Cambridge.

Vector Bioscience Cambridge has established a new collaboration with researchers from the University of Glasgow to develop and evaluate a

We are pleased to announce that Vector Bioscience Cambridge has joined the Milner Therapeutics Institute as an Affiliated Company. The

We are pleased to announce that Vector Bioscience Cambridge has joined the EU4MOFs COST Action network, a European initiative focused

We are pleased to announce that Vector Bioscience Cambridge is now an official member of the BioIndustry Association (BIA), the

Elena Avila / January 14, 2025

Vector Bioscience Shortlisted for Business Weekly Awards 2024 We are delighted to share that Vector Bioscience Cambridge was shortlisted in

Elena Avila / January 14, 2025

Lluna Gallego joins Panel at Cambridge Judge Business School We are pleased to share that our co-founder, Lluna Gallego, participated